维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Alsinet"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma显示文摘	Augusto Villanueva Yujin Hoshida Carlo Battiston Victoria Tovar Daniela Sia Clara Alsinet Helena Cornella Arthur Liberzon Masahiro Kobayashi Hiromitsu Kumada Swan N. Thung Jordi Bruix Philippa Newell Craig April Jian–Bing Fan Sasan Roayaie Vincenzo Mazzaf	2011	Gastroenterology2011，，5：	3
2	Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib显示文摘	Anja Lachenmayer Clara Alsinet Radoslav Savic Laia Cabellos Sara Toffanin Yujin Hoshida Augusto Villanueva Beatriz Minguez Philippa Newell Hung-Wen Tsai Jordi Barretina Swan Thung Stephen C. Ward Jordi Bruix Vincenzo Mazzaferro Myron Schwartz Scott L. Fri	2012	Clinical Cancer Research2012，，18：	2
3	Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma显示文摘	Augusto Villanueva Derek Y. Chiang Pippa Newell Judit Peix Swan Thung Clara Alsinet Victoria Tovar Sasan Roayaie Beatriz Minguez Manel Sole Carlo Battiston Stijn van Laarhoven Maria I. Fiel Analisa Di Feo Yujin Hoshida Steven Yea Sara Toffanin Alex Ramos	2008	Gastroenterology2008，，6：	1
4	Gene signatures in the management of hepatocellular carcinoma 显示文摘	Hoshida Y Moeini A Alsinet C	2012	Semin Oncol2012，39，4：	1
5	Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib显示文摘	Anja Lachenmayer Sara Toffanin Laia Cabellos Clara Alsinet Yujin Hoshida Augusto Villanueva Beatriz Minguez Hung-Wen Tsai Stephen C. Ward Swan Thung Scott L. Friedman Josep M. Llovet	2012	Journal of Hepatology2012，，6：	1
6	IGF activation in a mo- lecular subclass of hepatocellular carcinoma and pre-clinical effica- cy of IGF-I R blockage 显示文摘	Tovar V Alsinet C Villanueva A	2010	J Hepatol2010，52，4：	1
7	Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib显示文摘	Anja Lachenmayer Clara Alsinet Radoslav Savic Laia Cabellos Sara Toffanin Yujin Hoshida Augusto Villanueva Beatriz Minguez Philippa Newell Hung-Wen Tsai Jordi Barretina Swan Thung Stephen C. Ward Jordi Bruix Vincenzo Mazzaferro Myron Schwartz Scott L. Fri	2012	Clinical Cancer Research2012，，18：	1
8	IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage显示文摘	Tovar V Alsinet C Villanueva A	2010	J Hepatol2010，52，4：	1
9	Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
10	Wnt - pathway activation in two molecular classes of hepatocellular carcinoma and experi- mental modulation by sorafenib 显示文摘	J Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
11	Wnt-pathway activation intwo molecular classes of hepatocellular carcinoma and experimentalmodulation by sorafenib 显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
12	IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage显示文摘	Victoria Tovar Clara Alsinet Augusto Villanueva Yujin Hoshida Derek Y. Chiang Manel Solé Swan Thung Susana Moyano Sara Toffanin Beatriz Mínguez Laia Cabellos Judit Peix Myron Schwartz Vincenzo Mazzaferro Jordi Bruix Josep M. Llovet	2010	Journal of Hepatology2010，，4：	1
13	VEGF signaling in cancer treatment 显示文摘	Sia D Alsinet C Newell P	2014	Curr Pharm Des2014，20，17：	1
14	IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage显示文摘	Victoria Tovar Clara Alsinet Augusto Villanueva Yujin Hoshida Derek Y. Chiang Manel Solé Swan Thung Susana Moyano Sara Toffanin Beatriz Mínguez Laia Cabellos Judit Peix Myron Schwartz Vincenzo Mazzaferro Jordi Bruix Josep M. Llovet	2010	Journal of Hepatology2010，，4：	1
15	Wnt-pathway activa- tion in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
16	Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes显示文摘	Daniela Sia Yujin Hoshida Augusto Villanueva Sasan Roayaie Joana Ferrer Barbara Tabak Judit Peix Manel Sole Victoria Tovar Clara Alsinet Helena Cornella Brandy Klotzle Jian–Bing Fan Christian Cotsoglou Swan N. Thung Josep Fuster Samuel Waxman Juan Carlos	2013	Gastroenterology2013，，4：	1
17	Wnt-Pathway Activa- tion in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
18	One patient, two le- sions,two oncogenic drivers of gastric cancer显示文摘	Alsinet C Ranzani M Adams DJ	2014	Genome Biol2014，15，8：	1
19	Molecular approaches to treatment of hepatocellular carcinoma 显示文摘	Lachenmayer A Alsinet C hang CY Llovet JM	2010	Dig Liver Dis2010，42，3：	1
20	VEGF signaling in cancer treat- ment显示文摘	Sia D Alsinet C Newell P	2014	Curr Pharml Des2014，20，17：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示